Suppr超能文献

人脐带血源 AC133+祖细胞在长期体外扩增后保持内皮祖细胞特性。

Human cord blood-derived AC133+ progenitor cells preserve endothelial progenitor characteristics after long term in vitro expansion.

机构信息

Cellular and Molecular Imaging Laboratory, Department of Radiology, Henry Ford Hospital, Detroit, Michigan, United States of America.

出版信息

PLoS One. 2010 Feb 11;5(2):e9173. doi: 10.1371/journal.pone.0009173.

Abstract

BACKGROUND

Stem cells/progenitors are central to the development of cell therapy approaches for vascular ischemic diseases. The crucial step in rescuing tissues from ischemia is improvement of vascularization that can be achieved by promoting neovascularization. Endothelial progenitor cells (EPCs) are the best candidates for developing such an approach due to their ability to self-renew, circulate and differentiate into mature endothelial cells (ECs). Studies showed that intravenously administered progenitors isolated from bone marrow, peripheral or cord blood home to ischemic sites. However, the successful clinical application of such transplantation therapy is limited by low quantities of EPCs that can be generated from patients. Hence, the ability to amplify the numbers of autologous EPCs by long term in vitro expansion while preserving their angiogenic potential is critically important for developing EPC based therapies. Therefore, the objective of this study was to evaluate the capacity of cord blood (CB)-derived AC133+ cells to differentiate, in vitro, towards functional, mature endothelial cells (ECs) after long term in vitro expansion.

METHODOLOGY

We systematically characterized the properties of CB AC133+ cells over the 30 days of in vitro expansion. During 30 days of culturing, CB AC133+ cells exhibited significant growth potential that was manifested as 148-fold increase in cell numbers. Flow cytometry and immunocytochemistry demonstrated that CB AC133+ cells' expression of endothelial progenitor markers was not affected by long term in vitro culturing. After culturing under EC differentiation conditions, cells exhibited high expression of mature ECs markers, such as CD31, VEGFR-2 and von Willebrand factor, as well as the morphological changes indicative of differentiation towards mature ECs. In addition, throughout the 30 day culture cells preserved their functional capacity that was demonstrated by high uptake of DiI fluorescently conjugated-acetylated-low density lipoprotein (DiI-Ac-LDL), in vitro and in vivo migration towards chemotactic stimuli and in vitro tube formation.

CONCLUSIONS

These studies demonstrate that primary CB AC133+ culture contained mainly EPCs and that long term in vitro conditions facilitated the maintenance of these cells in the state of commitment towards endothelial lineage.

摘要

背景

干细胞/祖细胞是血管缺血性疾病细胞治疗方法发展的核心。从缺血中拯救组织的关键步骤是通过促进血管生成来改善血管生成,内皮祖细胞 (EPC) 是开发这种方法的最佳候选者,因为它们具有自我更新、循环和分化为成熟内皮细胞 (EC) 的能力。研究表明,静脉内给予从骨髓、外周血或脐带血分离的祖细胞可归巢到缺血部位。然而,这种移植治疗的成功临床应用受到从患者中产生的 EPC 数量有限的限制。因此,能够在体外长期扩增的同时保持其血管生成潜能,从而扩增自体 EPC 的数量,对于开发基于 EPC 的治疗方法至关重要。因此,本研究的目的是评估脐带血 (CB) 衍生的 AC133+细胞在体外长期扩增后分化为功能性成熟内皮细胞 (EC) 的能力。

方法

我们系统地描述了 CB AC133+细胞在体外扩增 30 天过程中的特性。在 30 天的培养过程中,CB AC133+细胞表现出显著的生长潜力,细胞数量增加了 148 倍。流式细胞术和免疫细胞化学显示,CB AC133+细胞的内皮祖细胞标记物的表达不受长期体外培养的影响。在 EC 分化条件下培养后,细胞表现出成熟 EC 标志物的高表达,如 CD31、VEGFR-2 和血管性血友病因子,以及向成熟 EC 分化的形态学变化。此外,在整个 30 天的培养过程中,细胞保持其功能能力,这表现在高摄取 DiI 荧光标记的乙酰化低密度脂蛋白 (DiI-Ac-LDL)、体外和体内向趋化刺激物的迁移以及体外管形成。

结论

这些研究表明,初级 CB AC133+培养物主要含有 EPC,并且长期体外条件有利于这些细胞维持向内皮谱系的定向状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ad/2820083/ba93766954ab/pone.0009173.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验